Observing disease progression of geographic atrophy in 3 siblings

Article

One way to advance the current understanding of GA is to study how disease progression varies among related individuals.

Image Credit: © Diego Cervo - stock.adobe.com

This study confirmed previous studies showing that choriocapillaris atrophy is associated with RPE loss while also identifying isolated nonexudative CNV in eyes with GA. (Image credit: Adobe Stock/Diego Cervo)

Researchers from Johns Hopkins in Baltimore, and the Bascom Palmer Eye Institute in Miami, joined together to conduct clinical imaging and histopathologic studies to gain a better understanding of geographic atrophy (GA) in 3 siblings who had been followed for 18 to 20 years.

Age-related macular degeneration (AMD) is a highly complex disease that involves many different cell types. One way to advance the current understanding of GA is to study how disease progression varies among related individuals,” according to lead author Malia M. Edwards, PhD, assistant professor, Wilmer Eye Institute, Johns Hopkins Hospital, underscoring the importance of a sibling study.

​In this study,1 2 of the 3 brothers underwent clinical imaging in 2016, 2 years before death. Immunohistochemistry of both flat-mounts and cross-sections, histology, and transmission electron microscopy images were used to compare the choroid and retina in eyes with GA to those of age-matched controls.

Study findings

Staining of the choroid with Ulex europaeus agglutinin lectin showed a significant reduction in the percent vascular area and vessel diameter. In one donor, histopathology showed 2 separate areas with choroidal neovascularization (CNV). Reevaluation of swept-source optical coherence tomography angiography (SS-OCTA) images showed the presence of CNV in 2 of the brothers.

Staining also identified a significant reduction in the retinal vasculature in the atrophic area. A subretinal glial membrane comprised of processes positive for glial fibrillary acidic protein and/or vimentin occupied areas identical to those of the retinal pigment epithelium (RPE) and choroidal atrophy in all 3 brothers. SS-OCTA also visualized presumed calcific drusen in the 2 donors who underwent imaging in 2016. Immunohistochemical analysis and alizarin red S staining verified calcium within the drusen, which was ensheathed by glial processes, the investigators reported.

In commenting on the findings, they said, “This study demonstrates the importance of clinicopathologic correlations to increasing our understanding of AMD. This study confirmed previous studies showing that choriocapillaris atrophy is associated with RPE loss while also identifying isolated nonexudative CNV in eyes with GA. It also demonstrated that subretinal glial cells create a membrane with junctions and a collagen component anterior to the region of RPE atrophy and choriocapillaris loss in GA. This membrane could create a barrier to treatments, including stem cell–derived therapy. This study also confirmed the presence of calcium in presumed calcified drusen seen on OCT imaging in 2 of the 3 three brothers.”

Reference:
1. Edwards MM, McLeod DS, Shen M, et al. Clinicopathologic findings in three siblings with geographic atrophy. Invest Ophthalmol Vis Sci. 2023;64:2; doi:https://doi.org/10.1167/iovs.64.3.2
Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
© 2025 MJH Life Sciences

All rights reserved.